01
Direct answer: how should remaining shelf life be reviewed?
Start with the labelled expiry date for the exact batch and state the date from which remaining shelf life is calculated. Identify the proposed handover or delivery date, expected transport and review time, storage profile, destination and the buyer’s documented acceptance criteria. The decision should show both the facts and who accepted them.
Do not replace the expiry date with a vague label such as “long date” or “short date”. Two organisations can apply different operational thresholds, and a batch that appears acceptable on the offer date may no longer meet the same criterion after approval, transport or customs time.
02
Expiry date, total shelf life and remaining shelf life are different
| Term | Meaning in the review | Record to retain |
|---|---|---|
| Labelled expiry date | The expiry shown on the authorised pack for the specific batch. | The exact month and year as presented, plus legible batch evidence. |
| Total shelf life | The authorised period assigned from manufacture or release under the product’s approved conditions. | Use authorised product information where the value is relevant and available. |
| Remaining shelf life | Time left from a stated checkpoint to the labelled expiry. | Calculation date, checkpoint and reproducible result. |
| Buyer acceptance period | The buyer’s minimum time remaining at the agreed point. | Approved criterion, responsible reviewer and any exception. |
| Operational buffer | Time allowed for review, dispatch, transport, receipt and onward handling. | Assumptions, route and the latest acceptable milestone date. |
Important: This is an inventory and transaction-control framework. It is not a clinical statement about whether a medicine should be prescribed, dispensed or used.
03
Regulatory and distribution controls that shape the review
Directive 2001/83/EC requires the expiry date in clear terms on medicine packaging and requires special storage precautions where applicable. EU Good Distribution Practice requires medicinal products to be protected from adverse temperature, light, moisture and other external factors and calls for stock rotation according to first expiry, first out (FEFO), with exceptions documented.
GDP also places importance on authorised supply chains, traceability, suitable storage and transport, complaints and recalls. These controls explain why expiry cannot be assessed in isolation: an apparently sufficient date does not correct an unsupported supply route, a storage excursion, damaged packaging or missing batch traceability.
04
A seven-step batch review before acceptance
- 01
Confirm the exact presentation
Match name, strength, form, route, pack size and product reference before attaching any expiry evidence.
- 02
Capture batch and expiry evidence
Record the batch identifier and labelled expiry from a legible source that relates to the proposed stock.
- 03
Choose the review checkpoint
State whether the threshold applies at offer, dispatch, delivery, release to saleable stock or another agreed milestone.
- 04
Calculate the operational timeline
Allow for approval, documentation, transport, receipt checks and a reasonable delay buffer.
- 05
Check storage and route
Review labelled storage conditions and whether the planned facilities and transport controls support them.
- 06
Apply documented acceptance criteria
Compare the projected remaining time at the checkpoint with the buyer and destination requirements.
- 07
Record acceptance or rejection
Retain the decision, reason, evidence date, reviewer and any approved exception in the transaction trail.
05
Common shelf-life review errors
For centrally authorised parallel-distribution presentations, EMA guidance states that mixing different batches and expiry dates to create one presentation is not allowed. More generally, separate batch records prevent an attractive aggregate quantity from obscuring materially different expiry profiles.
When facts change, recalculate rather than relying on the original result. A controlled record should show which values were current when the decision was made and make later changes visible.
- Calculating from today when the contract requires a threshold at delivery
- Recording only a percentage without the labelled expiry and calculation basis
- Applying one universal minimum to every product, route and buyer
- Ignoring approval, customs, quality-release or cold-chain lead time
- Combining quantities from different batches or expiry dates into one line
- Leaving old expiry information visible after a seller updates the available lot
- Assuming a discount makes an otherwise unacceptable timeline suitable
- Treating an expiry screenshot as proof of ownership, storage history or availability
06
Using remaining shelf life in an RFQ or batch offer
A buyer can state an objective minimum at a defined checkpoint, while a seller should provide the actual batch expiry rather than merely asserting compliance. The marketplace can calculate or display the interval consistently, but an authorised reviewer remains responsible for accepting the transaction-specific evidence.
PharmaBatch keeps the exact presentation, proposed quantity, batch expiry and workflow decision connected inside approved accounts. It does not certify product quality or decide clinical suitability. River Pharma GmbH independently assesses the proposed wholesale transaction before deciding whether to accept the execution role under the published operating model.
07
Frequently asked questions
What is remaining shelf life for a pharmaceutical batch?
It is the time between a clearly stated checkpoint—such as the review or expected delivery date—and the labelled expiry date of that specific batch.
Is there one EU minimum remaining shelf life for every transaction?
No single threshold fits every product and transaction. The review must consider the applicable requirements, buyer criteria, destination, route, storage profile and operational timeline.
Should a seller provide a percentage or the actual expiry date?
The actual labelled expiry and batch evidence should be recorded. A percentage or month count is useful only when its calculation date and checkpoint are also clear.
Does an acceptable expiry prove that a batch can be supplied?
No. Product identity, authorisations, traceability, storage history, route, availability and transaction documents still require review.
08
Primary sources
Regulatory statements on this page are grounded in the following official sources. Always check the current record and guidance for a real transaction.